FRANKLIN PRESCRIPTIONS, INC., t/а Franklin Drug Center v. NEW YORK TIMES CO., SANDRA COBURN, JOHN DOE, JANE DOE
No. 04-3404
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT
September 12, 2005
PRECEDENTIAL. On Appeal from the United States District Court for the Eastern District of Pennsylvania. D.C. Civil Action No. 01-cv-00145. (Honorable Cynthia M. Rufe). Argued May 27, 2005.
Before: SCIRICA, Chief Judge, ALITO and GARTH, Circuit Judges
DAVID P. HEIM, ESQUIRE
Bochetto & Lentz, P.C.
1524 Locust Street
Philadelphia, Pennsylvania 19102
Attorneys for Appellant
CARL A. SOLANO, ESQUIRE (ARGUED)
Schnader Harrison Segal & Lewis LLP
1600 Market Street, Suite 3600
Philadelphia, Pennsylvania 19103
Attorney for Appellees
OPINION OF THE COURT
SCIRICA, Chief Judge.
Plaintiff/Appellant Franklin Prescriptions challenges the jury instructions in this defamation action under Pennsylvania law. At issue is whether plaintiff properly objected to the court‘s jury charge under
I.
Franklin Prescriptions, Inc., is a small pharmacy in Philadelphia specializing in fertility medications. In 1996, the company began marketing its niche products on the internet via an information-only website. The website allows Franklin Prescriptions’ customers to survey available products and pricing, but does not enable the online purchase of prescription drugs. Franklin Prescriptions only accepts drug orders by way of mail, telephone, fax, or in person, and only then with a doctor‘s prescription.
On October 25, 2000, the New York Times published an article entitled, “A Web Bazaar Turns into a Pharmaceutical Free For All.” The article addressed the risks of purchasing fertility drugs on the internet. It described “unscrupulous” and “cloak and dagger” websites that process online orders for controlled drugs without prescriptions. Franklin Prescriptions was not mentioned in the text, but the article contained a graphic insert with an image of the Franklin Prescriptions website that identified Franklin Prescriptions by name. The insert was placed next to a side-bar labeled “Safety Tips for Buying E-Medicines” that warned readers to “[a]void sites that fail or refuse to provide a United States address and phone number.” Although Franklin Prescriptions’ website did, in fact, list the
Franklin Prescriptions sued for defamation. The District Court denied the New York Times’ motion for summary judgment, finding a genuine issue of material fact on whether the newspaper published the article with reckless disregard for its falsity. The case went to trial, and the jury found thе article false and defamatory. But it awarded no damages, finding Franklin Prescriptions suffered no actual harm caused by the publication.
Before the jury was charged, Franklin Prescriptions submitted proposed jury instructions on presumed damages and defamation per se. Neither proposed instruction was given to the jury. The parties dispute whether Franklin Prescriptions objected to the lаck of a presumed damages instruction. Franklin Prescriptions submits that it did so—off the record—at an in camera charging conference held in chambers. The New York Times disputes this contention, maintaining that the presumed damages instruction was not discussed at the chambers charging conference. In its Memorandum Opinion and Order, the District Court rejected Franklin Prescriptions’ assertion, stating that “the Court terminated the conference before addressing Plaintiff‘s presumed damages instruction.”
In denying the motion for a new trial, the District Court held that Franklin Prescriptions failed to object to the lack of a presumed damages instruction under
II.
The District Court had diversity jurisdiction under
III.
A.
The District Court held that Franklin Prescriptions failed to preserve its presumed damages objection under
Merely proposing a jury instruction that differs from the charge given is insufficient to preserve an objection. Abuan v. Level 3 Communications, Inc., 353 F.3d 1158, 1172 (10th Cir. 2003); Caruso v. Forslund, 47 F.3d 27, 31 (2d Cir. 1995); Advisory Committee Note to
Nor does Franklin Prescriptions’ purported charging conference objection presеrve the issue. Franklin Prescriptions cites to Smith v. Borough of Wilkinsburg, 147 F.3d 272, 277-78 (3d Cir. 1998), where a party submitted a proposed jury instruction and later objected to its omission at an in camera charging conference. We found the objection preserved under Rule 51 because “the district court was fully apprised of [the party‘s] position, and it would serve no purpose to require counsel to have formally reasserted thе objection after the charge had been given to the jury.” Id. at 278.
But Smith is unavailing here. The premise of Smith was that the trial court was “fully apprised” of the party‘s objection and nevertheless rejected it. Both the parties and the District Court in Smith agreed there had been an objection and a definitive ruling on the issue. That is not the case here. Franklin Prescriptions’ alleged off-the-record objection is disputed by the New York Times. More importantly, it is flatly contradicted by the District Court, which stated that Franklin Prescriptions’ “recollection of the March 18, 2004 conference is inaccurate . . . . the Court terminated the conference before addressing Plaintiff‘s presumed damages instruction.” 2004 WL 1770296, at *5. Unlike Smith, there is no consensus that the District Court was fully apprised of Franklin Prescriptions’ objection and no indication of a definitive trial court ruling on the matter. Cf.
Furthermore, prior to charging the jury, the parties here were provided with a written draft of the court‘s proposed instructions and explicitly invited to lodge exceptions for the record. The record reveals no objеction to the omission of a presumed damages instruction. Franklin Prescriptions entered certain objections to the charge but remained silent on the issue of presumed damages. Nor did Franklin Prescriptions object to the relevant aspects of the special verdict form, which instructed the jury that it could not award damages absent a showing of actual harm. The verdict fоrm, like the proposed instructions, precluded an award of presumed damages. Franklin Prescriptions’ failure to object to either the court‘s instructions or the verdict sheet constitutes a failure to preserve its presumed damages objection. Neely v. Club Med Mgmt. Servs., Inc., 63 F.3d 166, 200 (3d Cir. 1995) (en banc).
But there is a more fundamental reason to reject Franklin Prescriptions’ presumed damages challenge—the plain lаnguage of
The District Court in this case adhered to the Rule 51 framework. The parties were provided with a written draft of the proposed jury charge and expressly invited to enter on-the-
B.
Under the plain error standard, we consider, inter alia, the “obviousness of the error, the significance of the interest” involved, and “the reputation of judicial proceedings if the error stands uncorrected.” United States v. Richards, 241 F.3d 335, 342 (3d Cir. 2001); see also Advisory Committee Notes to
“Although replete with First Amendment implications, a defamation suit fundamentally is a state cause of action.” Schiavone Constr. Co. v. Time Inc., 847 F.2d 1069, 1082 (3d Cir. 1988) (citations omitted). We apply Pennsylvania defamation law in this diversity matter, with due regard for the underlying First Amendment principles. Where a question of
At issue is whether omission of a presumed damages instruction constituted a fundamental error resulting in a miscarriage of justice under Pennsylvania law. The District Court ruled that Franklin Prescriptions was not entitled to an instruction on “presumed damages” under Pennsylvania law. 2004 WL 1770296, at *7 (post-trial opinion and order). “Presumed damages” allow a defamation plaintiff to recover compensatory damages without proving the defamatory statement caused actual harm. The rationale for this approach is that it may be unfair to require proof of actual harm to reputation because reputational injury is difficult to prove and measure. See W. Page Keеton et al., Prosser & Keeton on The Law of Torts § 116A, at 843 (5th ed. 1984). Before Gertz v. Robert Welch, Inc., 418 U.S. 323 (1974), presumed damages were available in Pennsylvania without constitutional limitations. See, e.g., Fox v. Kahn, 221 A.2d 181, 184 (Pa. 1966). In Gertz, however, the Supreme Court held that the First Amendment bars presumed damages absent a showing of “knowledge of falsity or reckless disregard for the truth.” 418 U.S. at 349; see also Dun & Bradstreet v. Greenmoss Builders, 472 U.S. 749 (1985) (limiting Gertz to cases where the
As support for the availability of presumed damages, Franklin Prescriptions cites to a standard form Pennsylvania jury instruction which provides: “[i]f you find that the defendant acted either intentionally or recklessly in publishing the false and defamatory communication you may presume that the plaintiff suffered both injury to his reputation and the emotional distress, mental anguish and humiliation such as would result from such a communication.” 2 Pa. Sug. Stan. Civ. J. Inst. § 13.10(B) (2d ed. 2003). In Frisk v. News Co., 523 A.2d 347, 354 (Pa. Super. Ct. 1986), the Pennsylvania Superior Court upheld the validity of this instruction.
But seven years after Frisk was decided, the Pennsylvania Superior Court again considered presumed damages in Walker v. Grand Central Sanitation, Inc., 634 A.2d 237 (Pa. Super. Ct. 1993). Walker held that “a defendant who publishes a statement which can be considered slander per se is liable for the proven, actual harm the publication causes.” Id. at 244. Under Walker, a slander per se plaintiff is required to show “general damages“—proof of harm to reputation or personal humiliation—but not “special damages“—proof of actual monetary loss. Id. at 243-44 (“the burden is on the plaintiff to establish at least general damages“); see also Brinich v. Jencka, 757 A.2d 388, 397 (Pa. Super. Ct. 2000) (“‘[A] defendant who publishes a statement which can be considered slander per se is liable for the proven, actual harm the
Even if we assume, favorably to Franklin Prescriptions, that Walker allows an award of presumed damages upon a jury finding of actual malice, the jury here made no such finding. Question five of the verdict sheet, to which Franklin Prescriptions never objected, аsked the jury to determine the following:
Did Franklin Prescriptions, Inc. satisfy its burden of proving by a preponderance of the evidence that The New York Times acted intentionally, recklessly or negligently when it published the defamatory implication(s) in the article?
Question six of the verdict sheet, in turn, instructed the jury to return to the courtroom if it found insufficient evidence of actual harm. Franklin Prescriptions did not object to this question, which asked the jury:
Did Franklin Prescriptions, Inc., satisfy its burden of proving by a preponderance of the evidence that Franklin suffered actual harm that was substantially caused by the article?
Answering question six in the negative, the jury found no actual harm and returned to the courtroom without answering the subsequent verdict sheet questions concerning actual malice.
In sum, it appears that Pennsylvania law is unsettled on the аvailability of presumed damages in this case. Cf. United States v. Vazquez, 271 F.3d 93, 100 (3d Cir. 2001) (explaining that error is plain only where the proper course is “clear under current law“) (en banc); Connelly v. Hyundai Motor Co., 351 F.3d 535, 546 (1st Cir. 2003) (holding that error cannot be plain where current law is unsettled). In any event, we need not decide this issue. Even assuming Pennsylvania allows presumed damages upon a showing of actual malice, Franklin Prescriptions initially failed to enter an on-the-record objection to the lack of a presumed damages instruction and then acceded to a verdict sheet that compelled the jury to return to the courtroom before addressing the issue of actual malice.3 Because Franklin Prescriptions failed to seek or obtain an antecedent jury finding of actual malice, we see no prejudice
IV.
Franklin Prescriptions also contends it was entitled to an instruction on defamation per se. According to Franklin Prescriptions, the District Court‘s failure to issue a “defamation per se” charge mistakenly instructed the jury that proof of specific financial harm was required to support an award of compensatory damages. Franklin Prescriptions properly objected at trial to the lack of a defamation per se instruction.
Defamation or slander per se occurs where a publication “imputes to another conduct, characteristics, or a condition that would adversely affect her in her lawful business or trade[.]” Walker, 634 A.2d at 241. A defamation per se plaintiff need not prove “special damages,” i.e., monetary or out-of-pocket loss. Instead, a plaintiff need only prove “general damages,” i.e., “proof that one‘s reputation was actually affected by the slander, or that she suffered pеrsonal humiliation, or both.” Id. at 242.
The jury charge, while omitting the term “defamation per se,” made clear that Franklin Prescriptions was not required to prove financial harm. The jury charge was explicit that “actual injury can include impairment of reputation,” that Franklin
V. Conclusion
For the foregoing reasons, we will affirm the denial of the motion for a new trial.
